A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention
1Department of Emergency, the First Affiliated Hospital, Guangxi Medical University; Guangxi-China
Anatol J Cardiol 2021; 1(25): 7-16 PubMed ID: 33382055 DOI: 10.14744/AnatolJCardiol.2020.99469
Full Text PDF